Senin, 04 November 2019

Google Alert - GE

Google
GE
Daily update November 5, 2019
NEWS
The further General Electric moves away from its historical write-downs and bad acquisitions, the more willing new long-term investors are to take a ...
Facebook Twitter Flag as irrelevant
That said, GE highlighted the following factors as being responsible for the increase in FCF guidance at the midpoint of $1 billion from the second ...
Facebook Twitter Flag as irrelevant
Shares of General Electric (NYSE:GE) traded up more than 4.5% on Monday as Wall Street continues to digest -- and applaud -- the industrial ...
Facebook Twitter Flag as irrelevant
GE will retain its lucrative digital business—not spin it off, as had been planned—but it will sharpen the division's focus on four key markets, including ...
Facebook Twitter Flag as irrelevant
GE's stock is breaking out, and it may head towards $12.35 based on the chart. The PE ratio is currently historical high. The stock will need higher ...
Facebook Twitter Flag as irrelevant
AUSTIN, Texas--(BUSINESS WIRE)--. Leased Asset Documents Streamlined with Digital Records and Project Management System. GE Aviation has ...
Facebook Twitter Flag as irrelevant
General Electric reported Q3 2019 results that beat the top- and bottom-line estimates. The operating results were well-received by the market but I ...
Facebook Twitter Flag as irrelevant
General Electric (GE +4.9%) surges to its highest since late February as Wall Street analysts continue to weigh in on the company after gaining more ...
Facebook Twitter Flag as irrelevant
Over the last twelve months General Electric has recorded a ROE of 2.2%. One way to conceptualize this, is that for each $1 of shareholders' equity it ...
Facebook Twitter Flag as irrelevant
The FDA approves GE Healthcare's (GE +4.3%) Clariscan (gadoterate meglumine), a gadolinium-based contrast agent used MRI imaging in brain, ...
Facebook Twitter Flag as irrelevant
WEB
GE Healthcare announces US FDA approval of macrocyclic MRI contrast agent Clariscan
Clariscan, approved in more than 55 countries globally with over four million patient doses shipped, is now FDA-approved in the U.S. Expands the GE ...
Facebook Twitter Flag as irrelevant
See more results | Edit this alert
You have received this email because you have subscribed to Google Alerts.
RSS Receive this alert as RSS feed
Send Feedback

Tidak ada komentar:

Posting Komentar